

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pigment cell differentiation (GO:0050931) | 7.31629360 |
| 2 | melanocyte differentiation (GO:0030318) | 7.23858909 |
| 3 | basement membrane organization (GO:0071711) | 7.06681145 |
| 4 | developmental pigmentation (GO:0048066) | 6.46821049 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.02295960 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 6.02295960 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.90541705 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 5.90541705 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 5.56952149 |
| 10 | lymph vessel development (GO:0001945) | 5.54441912 |
| 11 | high-density lipoprotein particle remodeling (GO:0034375) | 5.51945827 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 5.43663059 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.36851244 |
| 14 | response to dietary excess (GO:0002021) | 5.14559704 |
| 15 | phenol-containing compound biosynthetic process (GO:0046189) | 5.05656375 |
| 16 | regulation of early endosome to late endosome transport (GO:2000641) | 5.00955764 |
| 17 | purine ribonucleotide transport (GO:0015868) | 4.99553690 |
| 18 | regulation of fibrinolysis (GO:0051917) | 4.97158647 |
| 19 | tryptophan catabolic process (GO:0006569) | 4.90134745 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 4.90134745 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 4.90134745 |
| 22 | reverse cholesterol transport (GO:0043691) | 4.87433491 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.84172532 |
| 24 | protein carboxylation (GO:0018214) | 4.84172532 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.81496660 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.75670071 |
| 27 | bile acid biosynthetic process (GO:0006699) | 4.74889901 |
| 28 | tryptophan metabolic process (GO:0006568) | 4.73847281 |
| 29 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.65383433 |
| 30 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.65383433 |
| 31 | endosome to melanosome transport (GO:0035646) | 4.56915991 |
| 32 | endosome to pigment granule transport (GO:0043485) | 4.56915991 |
| 33 | alpha-linolenic acid metabolic process (GO:0036109) | 4.54104575 |
| 34 | transcytosis (GO:0045056) | 4.53518671 |
| 35 | positive regulation of neuroblast proliferation (GO:0002052) | 4.53326988 |
| 36 | pigment biosynthetic process (GO:0046148) | 4.51750680 |
| 37 | triglyceride homeostasis (GO:0070328) | 4.44993357 |
| 38 | acylglycerol homeostasis (GO:0055090) | 4.44993357 |
| 39 | urea cycle (GO:0000050) | 4.41949447 |
| 40 | urea metabolic process (GO:0019627) | 4.41949447 |
| 41 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.40917586 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.38824729 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.38824729 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.38824729 |
| 45 | neuroepithelial cell differentiation (GO:0060563) | 4.38776282 |
| 46 | melanosome organization (GO:0032438) | 4.36169623 |
| 47 | sulfur amino acid catabolic process (GO:0000098) | 4.34319125 |
| 48 | secondary metabolic process (GO:0019748) | 4.32001699 |
| 49 | regulation of protein activation cascade (GO:2000257) | 4.30948591 |
| 50 | purine nucleotide transport (GO:0015865) | 4.29003008 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.27914957 |
| 52 | sexual reproduction (GO:0019953) | 4.27249071 |
| 53 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.27222273 |
| 54 | cysteine metabolic process (GO:0006534) | 4.20534709 |
| 55 | endothelium development (GO:0003158) | 4.17175089 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 4.16659421 |
| 57 | lymphangiogenesis (GO:0001946) | 4.16091748 |
| 58 | protein retention in ER lumen (GO:0006621) | 4.13732693 |
| 59 | phospholipid efflux (GO:0033700) | 4.13719908 |
| 60 | enteric nervous system development (GO:0048484) | 4.13185114 |
| 61 | pigment granule organization (GO:0048753) | 4.13050576 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.12490801 |
| 63 | complement activation, alternative pathway (GO:0006957) | 4.09537509 |
| 64 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.07364530 |
| 65 | adhesion of symbiont to host (GO:0044406) | 4.07230921 |
| 66 | nitrogen cycle metabolic process (GO:0071941) | 4.02993086 |
| 67 | regulation of complement activation (GO:0030449) | 4.02967034 |
| 68 | bile acid metabolic process (GO:0008206) | 4.02612845 |
| 69 | serine family amino acid catabolic process (GO:0009071) | 4.02447371 |
| 70 | lysine metabolic process (GO:0006553) | 3.96901599 |
| 71 | lysine catabolic process (GO:0006554) | 3.96901599 |
| 72 | semaphorin-plexin signaling pathway (GO:0071526) | 3.96154914 |
| 73 | adhesion of symbiont to host cell (GO:0044650) | 3.95051591 |
| 74 | virion attachment to host cell (GO:0019062) | 3.95051591 |
| 75 | aromatic amino acid family metabolic process (GO:0009072) | 3.93581554 |
| 76 | tyrosine metabolic process (GO:0006570) | 3.91314799 |
| 77 | protein heterotrimerization (GO:0070208) | 3.91259628 |
| 78 | endothelial cell morphogenesis (GO:0001886) | 3.87674161 |
| 79 | negative regulation of cholesterol transport (GO:0032375) | 3.87255306 |
| 80 | negative regulation of sterol transport (GO:0032372) | 3.87255306 |
| 81 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.86244637 |
| 82 | homocysteine metabolic process (GO:0050667) | 3.85086385 |
| 83 | drug catabolic process (GO:0042737) | 3.84469461 |
| 84 | negative regulation of focal adhesion assembly (GO:0051895) | 3.82140124 |
| 85 | negative regulation of cell junction assembly (GO:1901889) | 3.82140124 |
| 86 | negative regulation of adherens junction organization (GO:1903392) | 3.82140124 |
| 87 | cholesterol efflux (GO:0033344) | 3.74889867 |
| 88 | regulation of lipoprotein particle clearance (GO:0010984) | 3.74441193 |
| 89 | blood coagulation, intrinsic pathway (GO:0007597) | 3.71671353 |
| 90 | alpha-amino acid catabolic process (GO:1901606) | 3.70685995 |
| 91 | arginine metabolic process (GO:0006525) | 3.70234841 |
| 92 | cellular response to nitric oxide (GO:0071732) | 3.68315640 |
| 93 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.67491113 |
| 94 | fibrinolysis (GO:0042730) | 3.65042348 |
| 95 | glial cell migration (GO:0008347) | 3.64836979 |
| 96 | pigment metabolic process (GO:0042440) | 3.63635307 |
| 97 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.62551331 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.62056796 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.59734181 |
| 100 | protein activation cascade (GO:0072376) | 3.59239624 |
| 101 | amino-acid betaine metabolic process (GO:0006577) | 3.59102958 |
| 102 | sterol homeostasis (GO:0055092) | 3.58429554 |
| 103 | bile acid and bile salt transport (GO:0015721) | 3.57855784 |
| 104 | pigmentation (GO:0043473) | 3.56698546 |
| 105 | exogenous drug catabolic process (GO:0042738) | 3.55895930 |
| 106 | cellular ketone body metabolic process (GO:0046950) | 3.54798175 |
| 107 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.54601990 |
| 108 | benzene-containing compound metabolic process (GO:0042537) | 3.52420608 |
| 109 | urate metabolic process (GO:0046415) | 3.50452217 |
| 110 | negative regulation of hemostasis (GO:1900047) | 3.49887143 |
| 111 | negative regulation of blood coagulation (GO:0030195) | 3.49887143 |
| 112 | chondroitin sulfate catabolic process (GO:0030207) | 3.48674841 |
| 113 | positive regulation of odontogenesis (GO:0042482) | 3.46510574 |
| 114 | plasma lipoprotein particle assembly (GO:0034377) | 3.42039003 |
| 115 | indolalkylamine metabolic process (GO:0006586) | 3.42016997 |
| 116 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.41794094 |
| 117 | hyaluronan catabolic process (GO:0030214) | 3.40511602 |
| 118 | cellular amino acid catabolic process (GO:0009063) | 3.39177043 |
| 119 | cell migration involved in heart development (GO:0060973) | 3.37512075 |
| 120 | negative regulation of lipase activity (GO:0060192) | 3.35528228 |
| 121 | barbed-end actin filament capping (GO:0051016) | 3.35262543 |
| 122 | positive regulation of hemostasis (GO:1900048) | 3.32807559 |
| 123 | positive regulation of blood coagulation (GO:0030194) | 3.32807559 |
| 124 | heme transport (GO:0015886) | 3.32139794 |
| 125 | cellular modified amino acid catabolic process (GO:0042219) | 3.32008753 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.31974609 |
| 127 | glycine metabolic process (GO:0006544) | 3.31145570 |
| 128 | lipoprotein metabolic process (GO:0042157) | 3.30027240 |
| 129 | positive regulation of receptor recycling (GO:0001921) | 3.29833517 |
| 130 | sterol catabolic process (GO:0016127) | 3.27808100 |
| 131 | cholesterol catabolic process (GO:0006707) | 3.27808100 |
| 132 | cellular biogenic amine catabolic process (GO:0042402) | 3.27781668 |
| 133 | amine catabolic process (GO:0009310) | 3.27781668 |
| 134 | drug transmembrane transport (GO:0006855) | 3.25293326 |
| 135 | coenzyme catabolic process (GO:0009109) | 3.24994240 |
| 136 | regulation of neuroblast proliferation (GO:1902692) | 3.24696392 |
| 137 | positive regulation of coagulation (GO:0050820) | 3.22854235 |
| 138 | complement activation, classical pathway (GO:0006958) | 3.21201995 |
| 139 | negative regulation of coagulation (GO:0050819) | 3.20971945 |
| 140 | glutamate metabolic process (GO:0006536) | 3.20730408 |
| 141 | serine family amino acid metabolic process (GO:0009069) | 3.20463400 |
| 142 | cellular response to reactive nitrogen species (GO:1902170) | 3.19292047 |
| 143 | protein maturation by protein folding (GO:0022417) | 3.19172130 |
| 144 | protein localization to endosome (GO:0036010) | 3.18427339 |
| 145 | gap junction assembly (GO:0016264) | 3.18314852 |
| 146 | aldehyde catabolic process (GO:0046185) | 3.17600217 |
| 147 | cellular glucuronidation (GO:0052695) | 3.16745003 |
| 148 | protein-lipid complex subunit organization (GO:0071825) | 3.16463027 |
| 149 | complement activation (GO:0006956) | 3.16064774 |
| 150 | COPI coating of Golgi vesicle (GO:0048205) | 3.10251495 |
| 151 | Golgi transport vesicle coating (GO:0048200) | 3.10251495 |
| 152 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.04698503 |
| 153 | amyloid precursor protein catabolic process (GO:0042987) | 3.04189871 |
| 154 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.00210278 |
| 155 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.99366308 |
| 156 | dermatan sulfate metabolic process (GO:0030205) | 2.98999812 |
| 157 | dermatan sulfate biosynthetic process (GO:0030208) | 2.97883797 |
| 158 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.97780187 |
| 159 | activation of JUN kinase activity (GO:0007257) | 2.97038173 |
| 160 | amino sugar catabolic process (GO:0046348) | 2.96994176 |
| 161 | response to thyroid hormone (GO:0097066) | 2.94825353 |
| 162 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.88935885 |
| 163 | peptidyl-proline hydroxylation (GO:0019511) | 2.88003070 |
| 164 | negative regulation of chemokine production (GO:0032682) | 2.84098288 |
| 165 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.82075788 |
| 166 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.80215184 |
| 167 | negative regulation of macroautophagy (GO:0016242) | 2.76405848 |
| 168 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75572141 |
| 169 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.75489693 |
| 170 | pinocytosis (GO:0006907) | 2.75375915 |
| 171 | keratan sulfate catabolic process (GO:0042340) | 2.74428590 |
| 172 | protein kinase C signaling (GO:0070528) | 2.68069598 |
| 173 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.67204383 |
| 174 | regulation of superoxide anion generation (GO:0032928) | 2.66767526 |
| 175 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.65262843 |
| 176 | GDP-mannose metabolic process (GO:0019673) | 2.65206824 |
| 177 | skin morphogenesis (GO:0043589) | 2.63209610 |
| 178 | response to nitric oxide (GO:0071731) | 2.60865820 |
| 179 | mitotic G1/S transition checkpoint (GO:0044819) | 2.59492733 |
| 180 | oligodendrocyte differentiation (GO:0048709) | 2.57342107 |
| 181 | response to methylmercury (GO:0051597) | 2.52820460 |
| 182 | peripheral nervous system development (GO:0007422) | 2.52730368 |
| 183 | N-acetylneuraminate metabolic process (GO:0006054) | 2.50854412 |
| 184 | neural crest cell migration (GO:0001755) | 2.48347229 |
| 185 | UV protection (GO:0009650) | 2.46843410 |
| 186 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.45354405 |
| 187 | axon extension involved in axon guidance (GO:0048846) | 2.45354405 |
| 188 | collagen fibril organization (GO:0030199) | 2.45063944 |
| 189 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.44587520 |
| 190 | mannose metabolic process (GO:0006013) | 2.44336231 |
| 191 | extracellular fibril organization (GO:0043206) | 2.43744700 |
| 192 | morphogenesis of an endothelium (GO:0003159) | 2.40996394 |
| 193 | melanin biosynthetic process (GO:0042438) | 16.4822496 |
| 194 | melanin metabolic process (GO:0006582) | 15.0483543 |
| 195 | secondary metabolite biosynthetic process (GO:0044550) | 13.8320809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.84064746 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.86771858 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.93395797 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.46003971 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.36098546 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.25578509 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.56407399 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.95834733 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82044645 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.21555775 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.91980522 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.90146772 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.87664349 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.26689499 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17536033 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.14964193 |
| 17 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.11525278 |
| 18 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.03314977 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00135292 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98217149 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97609227 |
| 22 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.90594678 |
| 23 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.89499914 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84239897 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84203707 |
| 26 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.82654021 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.78926469 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72994489 |
| 29 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72780933 |
| 30 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70328269 |
| 31 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.66764468 |
| 32 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.65292297 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.64457743 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63086691 |
| 35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.62163022 |
| 36 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.61645736 |
| 37 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.60891020 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60577561 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58972208 |
| 40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.57775877 |
| 41 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.54301444 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53168711 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51075370 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49181255 |
| 45 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.48960939 |
| 46 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.48496516 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48409945 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48359337 |
| 49 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46641548 |
| 50 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.45508782 |
| 51 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44296370 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44048287 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42310765 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.42092972 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41301091 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41267615 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.39766863 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39138509 |
| 59 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38737186 |
| 60 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38695749 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38481185 |
| 62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.38100029 |
| 63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37566021 |
| 64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37207060 |
| 65 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.36572302 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36154897 |
| 67 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.34705236 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34007079 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30628611 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29692141 |
| 71 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.28630961 |
| 72 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.28564219 |
| 73 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.27813181 |
| 74 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.27010477 |
| 75 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26065509 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23991881 |
| 77 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.23852783 |
| 78 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19190369 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18417359 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17576834 |
| 81 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.17565386 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16955644 |
| 83 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.15826200 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15769845 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14885526 |
| 86 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14351986 |
| 87 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.13768314 |
| 88 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13247849 |
| 89 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.12561141 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12528279 |
| 91 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.12121624 |
| 92 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10354041 |
| 93 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.10113946 |
| 94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09640661 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09252789 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08342499 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08257054 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07831564 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07434940 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.07411893 |
| 101 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06841775 |
| 102 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.05009359 |
| 103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04518651 |
| 104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04148852 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03344819 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03064079 |
| 107 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02749235 |
| 108 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02404969 |
| 109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00702265 |
| 110 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00652952 |
| 111 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00250997 |
| 112 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99361652 |
| 113 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99333292 |
| 114 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98887857 |
| 115 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98791185 |
| 116 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.98356759 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95415827 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92863774 |
| 119 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90381303 |
| 120 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90381303 |
| 121 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90381303 |
| 122 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88543304 |
| 123 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87685943 |
| 124 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.87577235 |
| 125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86788490 |
| 126 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85684361 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83185307 |
| 128 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82714598 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81326040 |
| 130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80576342 |
| 131 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80549714 |
| 132 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78811888 |
| 133 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.78332355 |
| 134 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76931345 |
| 135 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.76827974 |
| 136 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.76827974 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75441282 |
| 138 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.74608991 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.72984379 |
| 140 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.71337240 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70753502 |
| 142 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.70748461 |
| 143 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.70623859 |
| 144 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67953025 |
| 145 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66552513 |
| 146 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.66157396 |
| 147 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65499113 |
| 148 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.65081887 |
| 149 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64624504 |
| 150 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.63965740 |
| 151 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.63146671 |
| 152 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62971401 |
| 153 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.62637739 |
| 154 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62158842 |
| 155 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.59679093 |
| 156 | * MAF_26560356_Chip-Seq_TH1_Human | 0.57970656 |
| 157 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57855125 |
| 158 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.56561696 |
| 159 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55282787 |
| 160 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.55097672 |
| 161 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53987190 |
| 162 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53679492 |
| 163 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53563396 |
| 164 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.52285833 |
| 165 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.52210774 |
| 166 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52021439 |
| 167 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.51641653 |
| 168 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.51598469 |
| 169 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.51012729 |
| 170 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.49803769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 9.15488155 |
| 2 | MP0000372_irregular_coat_pigmentation | 7.01732426 |
| 3 | MP0005360_urolithiasis | 6.30584081 |
| 4 | MP0005408_hypopigmentation | 6.10634662 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 5.68537461 |
| 6 | MP0003136_yellow_coat_color | 5.53460678 |
| 7 | MP0010368_abnormal_lymphatic_system | 5.53370075 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 4.76885886 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 4.61305450 |
| 10 | MP0000015_abnormal_ear_pigmentation | 4.42208220 |
| 11 | MP0005365_abnormal_bile_salt | 4.37622514 |
| 12 | MP0001879_abnormal_lymphatic_vessel | 4.04145876 |
| 13 | MP0004381_abnormal_hair_follicle | 3.93629371 |
| 14 | MP0005257_abnormal_intraocular_pressure | 3.67844105 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 3.61723741 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 3.55073406 |
| 17 | MP0003724_increased_susceptibility_to | 3.41573012 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 3.29430179 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 3.06619865 |
| 20 | MP0003252_abnormal_bile_duct | 2.94646323 |
| 21 | MP0002095_abnormal_skin_pigmentation | 2.93771797 |
| 22 | MP0000371_diluted_coat_color | 2.91378379 |
| 23 | MP0006054_spinal_hemorrhage | 2.90206159 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.85743734 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 2.81287625 |
| 26 | MP0009840_abnormal_foam_cell | 2.80807236 |
| 27 | MP0005174_abnormal_tail_pigmentation | 2.79636207 |
| 28 | MP0002075_abnormal_coat/hair_pigmentati | 2.32648430 |
| 29 | MP0002938_white_spotting | 2.29543933 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 2.29294355 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 2.28876537 |
| 32 | MP0005083_abnormal_biliary_tract | 2.14341486 |
| 33 | MP0005332_abnormal_amino_acid | 2.03211424 |
| 34 | MP0001186_pigmentation_phenotype | 1.96730932 |
| 35 | MP0004272_abnormal_basement_membrane | 1.95525610 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.93193352 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.90211125 |
| 38 | MP0003195_calcinosis | 1.87647489 |
| 39 | MP0001324_abnormal_eye_pigmentation | 1.83903939 |
| 40 | MP0000609_abnormal_liver_physiology | 1.81874069 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.79388335 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.77547672 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.77416348 |
| 44 | MP0005409_darkened_coat_color | 1.73414640 |
| 45 | MP0001666_abnormal_nutrient_absorption | 1.64789054 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.59463188 |
| 47 | MP0008004_abnormal_stomach_pH | 1.55027032 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.54160180 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.52392240 |
| 50 | MP0005248_abnormal_Harderian_gland | 1.38786842 |
| 51 | MP0005503_abnormal_tendon_morphology | 1.35783582 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.33374555 |
| 53 | MP0009697_abnormal_copulation | 1.33053088 |
| 54 | MP0003828_pulmonary_edema | 1.23096801 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19277610 |
| 56 | MP0001764_abnormal_homeostasis | 1.18659289 |
| 57 | MP0005197_abnormal_uvea_morphology | 1.16808266 |
| 58 | MP0000598_abnormal_liver_morphology | 1.16609377 |
| 59 | MP0003303_peritoneal_inflammation | 1.16528981 |
| 60 | MP0009764_decreased_sensitivity_to | 1.15153721 |
| 61 | MP0000249_abnormal_blood_vessel | 1.10235290 |
| 62 | MP0001851_eye_inflammation | 1.08945743 |
| 63 | MP0005670_abnormal_white_adipose | 1.08606025 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.04765500 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.04026281 |
| 66 | MP0008469_abnormal_protein_level | 1.03654072 |
| 67 | MP0000751_myopathy | 1.03397143 |
| 68 | MP0008260_abnormal_autophagy | 1.03284049 |
| 69 | MP0003868_abnormal_feces_composition | 1.02515123 |
| 70 | MP0009763_increased_sensitivity_to | 1.01421931 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 0.99918043 |
| 72 | MP0001756_abnormal_urination | 0.96310993 |
| 73 | MP0005451_abnormal_body_composition | 0.95586570 |
| 74 | MP0003186_abnormal_redox_activity | 0.94814558 |
| 75 | MP0001915_intracranial_hemorrhage | 0.93857496 |
| 76 | MP0001849_ear_inflammation | 0.93404716 |
| 77 | MP0004147_increased_porphyrin_level | 0.88184697 |
| 78 | MP0004883_abnormal_blood_vessel | 0.88169218 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 0.86316152 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.86268248 |
| 81 | MP0009053_abnormal_anal_canal | 0.84868395 |
| 82 | MP0005595_abnormal_vascular_smooth | 0.84838598 |
| 83 | MP0005164_abnormal_response_to | 0.84574498 |
| 84 | MP0002332_abnormal_exercise_endurance | 0.84130403 |
| 85 | MP0004130_abnormal_muscle_cell | 0.82242410 |
| 86 | MP0005165_increased_susceptibility_to | 0.81673512 |
| 87 | MP0000604_amyloidosis | 0.79162572 |
| 88 | MP0002060_abnormal_skin_morphology | 0.78868067 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.78474863 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.76585445 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.76271392 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.76146241 |
| 93 | MP0003283_abnormal_digestive_organ | 0.75452898 |
| 94 | MP0003075_altered_response_to | 0.75066940 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.73604027 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.72549693 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.72520030 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.72497398 |
| 99 | MP0005647_abnormal_sex_gland | 0.72418292 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.71365755 |
| 101 | MP0002177_abnormal_outer_ear | 0.70896831 |
| 102 | MP0000920_abnormal_myelination | 0.69795620 |
| 103 | MP0002254_reproductive_system_inflammat | 0.69731574 |
| 104 | MP0005508_abnormal_skeleton_morphology | 0.69704054 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.69169454 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.69059065 |
| 107 | MP0001958_emphysema | 0.68292003 |
| 108 | MP0000343_altered_response_to | 0.67624350 |
| 109 | MP0003690_abnormal_glial_cell | 0.67079514 |
| 110 | MP0002128_abnormal_blood_circulation | 0.64824111 |
| 111 | MP0003634_abnormal_glial_cell | 0.63465042 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.63454381 |
| 113 | MP0003638_abnormal_response/metabolism_ | 0.62955211 |
| 114 | MP0003011_delayed_dark_adaptation | 0.62683518 |
| 115 | MP0001661_extended_life_span | 0.62332264 |
| 116 | MP0005193_abnormal_anterior_eye | 0.60045913 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.59797306 |
| 118 | MP0008873_increased_physiological_sensi | 0.59185532 |
| 119 | MP0002419_abnormal_innate_immunity | 0.59097146 |
| 120 | MP0005023_abnormal_wound_healing | 0.57502826 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.56906286 |
| 122 | MP0003279_aneurysm | 0.56874296 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.56584626 |
| 124 | MP0002090_abnormal_vision | 0.55994692 |
| 125 | MP0001502_abnormal_circadian_rhythm | 0.55625923 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.55428364 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.55059853 |
| 128 | MP0003436_decreased_susceptibility_to | 0.54787407 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.54618739 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.54428416 |
| 131 | MP0001614_abnormal_blood_vessel | 0.54377234 |
| 132 | MP0000749_muscle_degeneration | 0.53878759 |
| 133 | MP0008874_decreased_physiological_sensi | 0.53369890 |
| 134 | MP0009384_cardiac_valve_regurgitation | 0.52889484 |
| 135 | MP0003959_abnormal_lean_body | 0.51851256 |
| 136 | MP0001835_abnormal_antigen_presentation | 0.50417480 |
| 137 | MP0000367_abnormal_coat/_hair | 0.50202491 |
| 138 | MP0006138_congestive_heart_failure | 0.49706135 |
| 139 | MP0009785_altered_susceptibility_to | 0.49423096 |
| 140 | MP0003091_abnormal_cell_migration | 0.48823423 |
| 141 | MP0004233_abnormal_muscle_weight | 0.48772279 |
| 142 | MP0002971_abnormal_brown_adipose | 0.48184015 |
| 143 | MP0001542_abnormal_bone_strength | 0.47987893 |
| 144 | MP0010155_abnormal_intestine_physiology | 0.47263647 |
| 145 | MP0002078_abnormal_glucose_homeostasis | 0.46588693 |
| 146 | MP0005025_abnormal_response_to | 0.46540272 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.45890310 |
| 148 | MP0001270_distended_abdomen | 0.45335727 |
| 149 | MP0006082_CNS_inflammation | 0.44910063 |
| 150 | MP0001881_abnormal_mammary_gland | 0.44869006 |
| 151 | MP0005275_abnormal_skin_tensile | 0.39888032 |
| 152 | MP0004858_abnormal_nervous_system | 0.39231284 |
| 153 | MP0000678_abnormal_parathyroid_gland | 0.36880378 |
| 154 | MP0000534_abnormal_ureter_morphology | 0.35143260 |
| 155 | MP0003385_abnormal_body_wall | 0.35071302 |
| 156 | MP0000467_abnormal_esophagus_morphology | 0.34923723 |
| 157 | MP0002933_joint_inflammation | 0.34446577 |
| 158 | MP0002998_abnormal_bone_remodeling | 0.33157580 |
| 159 | MP0002896_abnormal_bone_mineralization | 0.31716721 |
| 160 | MP0000759_abnormal_skeletal_muscle | 0.31510478 |
| 161 | MP0005390_skeleton_phenotype | 0.29876094 |
| 162 | MP0002970_abnormal_white_adipose | 0.29220586 |
| 163 | MP0003123_paternal_imprinting | 0.27815739 |
| 164 | MP0002106_abnormal_muscle_physiology | 0.27711543 |
| 165 | MP0008569_lethality_at_weaning | 0.27668448 |
| 166 | MP0005330_cardiomyopathy | 0.27430837 |
| 167 | MP0000750_abnormal_muscle_regeneration | 0.26860164 |
| 168 | MP0002751_abnormal_autonomic_nervous | 0.26775835 |
| 169 | MP0002092_abnormal_eye_morphology | 0.26080946 |
| 170 | MP0000747_muscle_weakness | 0.26053427 |
| 171 | MP0002108_abnormal_muscle_morphology | 0.25969409 |
| 172 | MP0008932_abnormal_embryonic_tissue | 0.25844565 |
| 173 | MP0000358_abnormal_cell_content/ | 0.25473526 |
| 174 | MP0003795_abnormal_bone_structure | 0.24980004 |
| 175 | MP0000639_abnormal_adrenal_gland | 0.24610865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | White forelock (HP:0002211) | 8.78540726 |
| 2 | Patchy hypopigmentation of hair (HP:0011365) | 7.92654457 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.40333693 |
| 4 | Ocular albinism (HP:0001107) | 7.19837931 |
| 5 | Aplasia/Hypoplasia of the macula (HP:0008059) | 6.62566291 |
| 6 | Iris hypopigmentation (HP:0007730) | 6.26862805 |
| 7 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 6.21075688 |
| 8 | Blue irides (HP:0000635) | 6.14062536 |
| 9 | Hypoplasia of the fovea (HP:0007750) | 5.82140921 |
| 10 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 5.82140921 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.76407764 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 5.56899982 |
| 13 | Nonimmune hydrops fetalis (HP:0001790) | 5.54602953 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 5.51522392 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.33927515 |
| 16 | Joint hemorrhage (HP:0005261) | 5.04661400 |
| 17 | Xanthomatosis (HP:0000991) | 5.04594817 |
| 18 | Hypopigmentation of the fundus (HP:0007894) | 4.92542052 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 4.74338325 |
| 20 | Abnormality of the fovea (HP:0000493) | 4.72283095 |
| 21 | Heterochromia iridis (HP:0001100) | 4.54143265 |
| 22 | Cerebral aneurysm (HP:0004944) | 4.47697949 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 4.42447474 |
| 24 | Protrusio acetabuli (HP:0003179) | 4.40962952 |
| 25 | Complement deficiency (HP:0004431) | 4.39931127 |
| 26 | Premature rupture of membranes (HP:0001788) | 4.21278516 |
| 27 | Hypoplasia of the iris (HP:0007676) | 4.12446594 |
| 28 | Generalized hypopigmentation (HP:0007513) | 4.10410828 |
| 29 | Hypolipoproteinemia (HP:0010981) | 4.05500402 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 4.05316165 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 4.02246954 |
| 32 | Vertebral compression fractures (HP:0002953) | 3.94430110 |
| 33 | Paraparesis (HP:0002385) | 3.76704857 |
| 34 | Polycythemia (HP:0001901) | 3.75885309 |
| 35 | Hyperammonemia (HP:0001987) | 3.74139679 |
| 36 | J-shaped sella turcica (HP:0002680) | 3.68307548 |
| 37 | Esophageal varix (HP:0002040) | 3.67978311 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.66398273 |
| 39 | Abnormal auditory evoked potentials (HP:0006958) | 3.62759265 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 3.62188023 |
| 41 | Spontaneous hematomas (HP:0007420) | 3.58698823 |
| 42 | Spastic paraparesis (HP:0002313) | 3.57168115 |
| 43 | Peripheral hypomyelination (HP:0007182) | 3.55407570 |
| 44 | Premature graying of hair (HP:0002216) | 3.55288094 |
| 45 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.51757386 |
| 46 | Albinism (HP:0001022) | 3.51567899 |
| 47 | Ketosis (HP:0001946) | 3.44773401 |
| 48 | Achilles tendon contracture (HP:0001771) | 3.34827896 |
| 49 | Vascular calcification (HP:0004934) | 3.30469429 |
| 50 | Abnormality of glycolipid metabolism (HP:0010969) | 3.27001793 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.27001793 |
| 52 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.27001793 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.25076550 |
| 54 | Abnormality of complement system (HP:0005339) | 3.22095523 |
| 55 | Hypoglycemic coma (HP:0001325) | 3.19184863 |
| 56 | Hyperglycinemia (HP:0002154) | 3.14446927 |
| 57 | Fat malabsorption (HP:0002630) | 3.14133963 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 3.13692651 |
| 59 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.08843277 |
| 60 | Hypercholesterolemia (HP:0003124) | 3.07761516 |
| 61 | Hyperglycinuria (HP:0003108) | 3.07598461 |
| 62 | Epidermoid cyst (HP:0200040) | 3.06247724 |
| 63 | Conjunctival telangiectasia (HP:0000524) | 3.05600964 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 3.04188214 |
| 65 | Myocardial infarction (HP:0001658) | 3.03289935 |
| 66 | Cardiovascular calcification (HP:0011915) | 3.03065589 |
| 67 | Hematochezia (HP:0002573) | 3.02908763 |
| 68 | Abnormality of methionine metabolism (HP:0010901) | 3.00890803 |
| 69 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.94033020 |
| 70 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.93317923 |
| 71 | Abnormality of glycine metabolism (HP:0010895) | 2.93317923 |
| 72 | Hepatocellular carcinoma (HP:0001402) | 2.90712331 |
| 73 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.86078775 |
| 74 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81535220 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.81326921 |
| 76 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.81230992 |
| 77 | Lymphangioma (HP:0100764) | 2.75734711 |
| 78 | Hemorrhage of the eye (HP:0011885) | 2.75682389 |
| 79 | Abnormality of purine metabolism (HP:0004352) | 2.75286320 |
| 80 | Hand muscle atrophy (HP:0009130) | 2.74048282 |
| 81 | Delayed CNS myelination (HP:0002188) | 2.72594049 |
| 82 | Distal upper limb amyotrophy (HP:0007149) | 2.72509418 |
| 83 | Upper limb amyotrophy (HP:0009129) | 2.72509418 |
| 84 | Alacrima (HP:0000522) | 2.68287897 |
| 85 | Ketoacidosis (HP:0001993) | 2.67067792 |
| 86 | Thrombophlebitis (HP:0004418) | 2.66098454 |
| 87 | Capillary hemangiomas (HP:0005306) | 2.65791027 |
| 88 | Cerebral hemorrhage (HP:0001342) | 2.64302298 |
| 89 | Shallow orbits (HP:0000586) | 2.61551190 |
| 90 | Glomerulonephritis (HP:0000099) | 2.60492398 |
| 91 | Gout (HP:0001997) | 2.56050698 |
| 92 | Conjugated hyperbilirubinemia (HP:0002908) | 2.54729436 |
| 93 | Ulnar bowing (HP:0003031) | 2.51509326 |
| 94 | Hyperbilirubinemia (HP:0002904) | 2.50643809 |
| 95 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.50296815 |
| 96 | Amyloidosis (HP:0011034) | 2.47777730 |
| 97 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.41377068 |
| 98 | Steatorrhea (HP:0002570) | 2.40164004 |
| 99 | Pulmonary embolism (HP:0002204) | 2.34708064 |
| 100 | Ankle contracture (HP:0006466) | 2.34445390 |
| 101 | Loss of speech (HP:0002371) | 2.34252588 |
| 102 | Spinal rigidity (HP:0003306) | 2.33545875 |
| 103 | Increased variability in muscle fiber diameter (HP:0003557) | 2.32519781 |
| 104 | Spastic diplegia (HP:0001264) | 2.30579094 |
| 105 | Congenital sensorineural hearing impairment (HP:0008527) | 2.30295258 |
| 106 | Elbow flexion contracture (HP:0002987) | 2.28024029 |
| 107 | Genu recurvatum (HP:0002816) | 2.24156948 |
| 108 | Spontaneous abortion (HP:0005268) | 2.20646953 |
| 109 | Dicarboxylic aciduria (HP:0003215) | 2.19951754 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.19951754 |
| 111 | Cerebral hypomyelination (HP:0006808) | 2.14968172 |
| 112 | Metabolic acidosis (HP:0001942) | 2.14652610 |
| 113 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14642897 |
| 114 | Mitral stenosis (HP:0001718) | 2.13782229 |
| 115 | Abnormality of dentin (HP:0010299) | 2.13245758 |
| 116 | Abnormality of the nasal mucosa (HP:0000433) | 2.10490918 |
| 117 | Distal lower limb muscle weakness (HP:0009053) | 2.10083254 |
| 118 | Menorrhagia (HP:0000132) | 2.08919051 |
| 119 | Morphological abnormality of the inner ear (HP:0011390) | 2.07826218 |
| 120 | Deformed sella turcica (HP:0002681) | 2.05406766 |
| 121 | Chondrocalcinosis (HP:0000934) | 2.05177973 |
| 122 | Stroke (HP:0001297) | 2.04820020 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04626065 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04626065 |
| 125 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04626065 |
| 126 | Increased cerebral lipofuscin (HP:0011813) | 2.04350074 |
| 127 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.04132005 |
| 128 | Abnormality of serum amino acid levels (HP:0003112) | 2.04048861 |
| 129 | Neonatal onset (HP:0003623) | 2.03712487 |
| 130 | Blue sclerae (HP:0000592) | 2.03298998 |
| 131 | Mucosal telangiectasiae (HP:0100579) | 2.03273958 |
| 132 | Cardiomegaly (HP:0001640) | 2.02187417 |
| 133 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.01349892 |
| 134 | Absent epiphyses (HP:0010577) | 2.01349892 |
| 135 | Axonal loss (HP:0003447) | 2.00662863 |
| 136 | Nephritis (HP:0000123) | 2.00528025 |
| 137 | Alkalosis (HP:0001948) | 2.00486231 |
| 138 | Hypoglycemic seizures (HP:0002173) | 1.99112997 |
| 139 | Microcytic anemia (HP:0001935) | 1.98988317 |
| 140 | Increased purine levels (HP:0004368) | 1.97967004 |
| 141 | Hyperuricemia (HP:0002149) | 1.97967004 |
| 142 | Irritability (HP:0000737) | 1.97532793 |
| 143 | Visceral angiomatosis (HP:0100761) | 1.97406935 |
| 144 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97337083 |
| 145 | Malnutrition (HP:0004395) | 1.96324780 |
| 146 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96295092 |
| 147 | Stridor (HP:0010307) | 1.95735873 |
| 148 | Freckling (HP:0001480) | 1.95575548 |
| 149 | Mesangial abnormality (HP:0001966) | 1.95538349 |
| 150 | Pancreatitis (HP:0001733) | 1.95501866 |
| 151 | Abnormal gallbladder physiology (HP:0012438) | 1.94922362 |
| 152 | Cholecystitis (HP:0001082) | 1.94922362 |
| 153 | Bulbar palsy (HP:0001283) | 1.94714138 |
| 154 | Hypochromic microcytic anemia (HP:0004840) | 1.93833298 |
| 155 | Decreased lacrimation (HP:0000633) | 1.93271583 |
| 156 | Abnormality of iron homeostasis (HP:0011031) | 1.90868009 |
| 157 | Skin nodule (HP:0200036) | 1.89258247 |
| 158 | Lethargy (HP:0001254) | 1.88302062 |
| 159 | Sensorimotor neuropathy (HP:0007141) | 1.88052619 |
| 160 | Joint stiffness (HP:0001387) | 1.87983896 |
| 161 | Abnormality of Sharpey fibers (HP:0100685) | 1.87920702 |
| 162 | Colitis (HP:0002583) | 1.86703994 |
| 163 | Hemangiomatosis (HP:0007461) | 1.86587506 |
| 164 | Prolonged neonatal jaundice (HP:0006579) | 1.86279115 |
| 165 | Cervical subluxation (HP:0003308) | 1.84299023 |
| 166 | Mucopolysacchariduria (HP:0008155) | 1.83790327 |
| 167 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83790327 |
| 168 | Trismus (HP:0000211) | 1.81494541 |
| 169 | Gingival bleeding (HP:0000225) | 1.80815523 |
| 170 | Abnormality of proline metabolism (HP:0010907) | 1.80485779 |
| 171 | Hydroxyprolinuria (HP:0003080) | 1.80485779 |
| 172 | Hyperacusis (HP:0010780) | 1.79585685 |
| 173 | Wormian bones (HP:0002645) | 1.79494816 |
| 174 | Increased connective tissue (HP:0009025) | 1.79395134 |
| 175 | Bladder diverticulum (HP:0000015) | 1.77254024 |
| 176 | Type 1 muscle fiber predominance (HP:0003803) | 1.75862749 |
| 177 | Vascular tortuosity (HP:0004948) | 1.74875136 |
| 178 | Soft skin (HP:0000977) | 1.73395148 |
| 179 | Asymmetric septal hypertrophy (HP:0001670) | 1.73207110 |
| 180 | Aortic dissection (HP:0002647) | 1.68875693 |
| 181 | Biconcave vertebral bodies (HP:0004586) | 1.67076725 |
| 182 | Round ear (HP:0100830) | 1.65526087 |
| 183 | Purpura (HP:0000979) | 1.65468022 |
| 184 | Generalized amyotrophy (HP:0003700) | 1.61533234 |
| 185 | Hypokinesia (HP:0002375) | 1.58871675 |
| 186 | Fragile skin (HP:0001030) | 1.58663444 |
| 187 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.58611542 |
| 188 | Follicular hyperkeratosis (HP:0007502) | 1.58212746 |
| 189 | Slender build (HP:0001533) | 1.54630550 |
| 190 | Aortic aneurysm (HP:0004942) | 1.54365973 |
| 191 | Morphological abnormality of the middle ear (HP:0008609) | 1.53263780 |
| 192 | Long toe (HP:0010511) | 1.53240873 |
| 193 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.52715237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 8.12765429 |
| 2 | WEE1 | 4.60458580 |
| 3 | TGFBR2 | 3.94390204 |
| 4 | PRKD3 | 3.65871477 |
| 5 | ERN1 | 3.59924413 |
| 6 | ICK | 2.79612404 |
| 7 | TGFBR1 | 2.70342722 |
| 8 | BCKDK | 2.47199319 |
| 9 | NME2 | 2.28946165 |
| 10 | LMTK2 | 2.15535129 |
| 11 | FGFR4 | 2.03977662 |
| 12 | KDR | 10.2163792 |
| 13 | DDR2 | 1.97732542 |
| 14 | PKN2 | 1.85077603 |
| 15 | MAPKAPK3 | 1.69236331 |
| 16 | TESK1 | 1.68634702 |
| 17 | RIPK1 | 1.62820488 |
| 18 | CDK7 | 1.61582211 |
| 19 | PTK6 | 1.57882042 |
| 20 | LIMK1 | 1.45651047 |
| 21 | PRKD2 | 1.40737179 |
| 22 | EPHB1 | 1.36597712 |
| 23 | GRK1 | 1.35370955 |
| 24 | SIK1 | 1.31649399 |
| 25 | CDC42BPA | 1.31512944 |
| 26 | MAP3K6 | 1.31271356 |
| 27 | JAK1 | 1.22852458 |
| 28 | MAP2K3 | 1.21599273 |
| 29 | TYK2 | 1.20257504 |
| 30 | TTN | 1.19776522 |
| 31 | TBK1 | 1.17452024 |
| 32 | PTK2B | 1.09534211 |
| 33 | INSRR | 1.08415371 |
| 34 | MYLK | 1.07819284 |
| 35 | FLT3 | 1.07485626 |
| 36 | TRIB3 | 1.04363866 |
| 37 | PRPF4B | 1.04320870 |
| 38 | EPHB2 | 1.01255125 |
| 39 | SIK2 | 1.00236559 |
| 40 | MAPK12 | 0.98732625 |
| 41 | SIK3 | 0.97983324 |
| 42 | JAK2 | 0.96790787 |
| 43 | MAP3K11 | 0.96185276 |
| 44 | CDK8 | 0.94232149 |
| 45 | MAP4K1 | 0.90811934 |
| 46 | NEK2 | 0.90188351 |
| 47 | JAK3 | 0.89522320 |
| 48 | MAP3K3 | 0.88939808 |
| 49 | MAPK15 | 0.83850619 |
| 50 | BRSK1 | 0.83244769 |
| 51 | MAP3K14 | 0.82261204 |
| 52 | ARAF | 0.80243759 |
| 53 | CSNK1G3 | 0.79329570 |
| 54 | MATK | 0.77911301 |
| 55 | NEK9 | 0.77738327 |
| 56 | TYRO3 | 0.74358785 |
| 57 | NTRK1 | 0.73927111 |
| 58 | DAPK2 | 0.73842660 |
| 59 | CSK | 0.72706156 |
| 60 | MAP4K2 | 0.70621055 |
| 61 | SMG1 | 0.70562835 |
| 62 | CAMK4 | 0.68652005 |
| 63 | MAP3K2 | 0.67519341 |
| 64 | MARK2 | 0.67482518 |
| 65 | FER | 0.67421432 |
| 66 | GRK5 | 0.66948194 |
| 67 | PAK4 | 0.66620114 |
| 68 | PDK2 | 0.66359927 |
| 69 | RPS6KA2 | 0.64899130 |
| 70 | WNK4 | 0.63322403 |
| 71 | PTK2 | 0.61337653 |
| 72 | STK38 | 0.60637296 |
| 73 | CSNK1G2 | 0.57451686 |
| 74 | BLK | 0.57248162 |
| 75 | TAOK3 | 0.56161765 |
| 76 | PIM2 | 0.54046064 |
| 77 | MAPK7 | 0.52336251 |
| 78 | BRAF | 0.51964731 |
| 79 | GSK3A | 0.51567704 |
| 80 | MET | 0.50967833 |
| 81 | CSF1R | 0.49644286 |
| 82 | MAPK11 | 0.48941885 |
| 83 | AKT2 | 0.48561159 |
| 84 | CDK3 | 0.46777426 |
| 85 | TESK2 | 0.46521332 |
| 86 | STK10 | 0.46195635 |
| 87 | MAP2K4 | 0.46075096 |
| 88 | ERBB4 | 0.45677518 |
| 89 | IGF1R | 0.45294202 |
| 90 | IKBKE | 0.44949737 |
| 91 | CDK11A | 0.44561516 |
| 92 | IRAK3 | 0.43939312 |
| 93 | HIPK2 | 0.43814619 |
| 94 | MAP2K2 | 0.43329516 |
| 95 | PRKG2 | 0.42970597 |
| 96 | MAP3K10 | 0.42850060 |
| 97 | RET | 0.42847439 |
| 98 | PAK1 | 0.42531526 |
| 99 | MAPK4 | 0.42171212 |
| 100 | ILK | 0.41248728 |
| 101 | EGFR | 0.41171465 |
| 102 | KIT | 0.40333883 |
| 103 | CSNK1G1 | 0.39695664 |
| 104 | CDK15 | 0.39284856 |
| 105 | MAP3K1 | 0.39103419 |
| 106 | ZAP70 | 0.38903645 |
| 107 | FGFR3 | 0.38490882 |
| 108 | PRKCH | 0.38146576 |
| 109 | STK16 | 0.37552116 |
| 110 | CDK9 | 0.35944908 |
| 111 | ABL2 | 0.35782741 |
| 112 | CDK18 | 0.35509779 |
| 113 | SCYL2 | 0.35020246 |
| 114 | PIK3CG | 0.34968152 |
| 115 | MTOR | 0.34575921 |
| 116 | TAOK2 | 0.34461790 |
| 117 | PRKAA2 | 0.34437741 |
| 118 | BMX | 0.33966242 |
| 119 | DMPK | 0.33708139 |
| 120 | TEC | 0.33563757 |
| 121 | LATS1 | 0.33133246 |
| 122 | CAMK1D | 0.32656374 |
| 123 | MST1R | 0.31479490 |
| 124 | FES | 0.30452930 |
| 125 | MAP2K1 | 0.29679814 |
| 126 | MOS | 0.28474585 |
| 127 | LYN | 0.28354070 |
| 128 | OXSR1 | 0.28089279 |
| 129 | LRRK2 | 0.27651866 |
| 130 | ITK | 0.26110646 |
| 131 | FGFR2 | 0.22019042 |
| 132 | DYRK1B | 0.21473341 |
| 133 | PRKD1 | 0.21440638 |
| 134 | EPHA3 | 0.21069919 |
| 135 | MARK3 | 0.20894986 |
| 136 | PDGFRA | 0.20644524 |
| 137 | CDK6 | 0.19465947 |
| 138 | PDPK1 | 0.19427719 |
| 139 | SRC | 0.19303296 |
| 140 | GRK6 | 0.19149235 |
| 141 | CSNK1A1L | 0.18536774 |
| 142 | MAP3K8 | 0.18244795 |
| 143 | INSR | 0.16057827 |
| 144 | MAP3K7 | 0.16039369 |
| 145 | PDK1 | 0.15492343 |
| 146 | PRKAA1 | 0.15347274 |
| 147 | LATS2 | 0.14741584 |
| 148 | FRK | 0.14628474 |
| 149 | MAP2K6 | 0.14001946 |
| 150 | PRKCQ | 0.13323001 |
| 151 | AKT3 | 0.13004774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43266586 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.47208482 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.36369251 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.28977958 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28146330 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19394582 |
| 7 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 3.07561872 |
| 8 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 3.01721575 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51235749 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.50277462 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44994511 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44376315 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37806858 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31146222 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28420245 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24076524 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.23413696 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06273171 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.00021378 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93841641 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93235892 |
| 22 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.89628833 |
| 23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.88759166 |
| 24 | Melanogenesis_Homo sapiens_hsa04916 | 1.87893647 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.81681909 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76833781 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74455713 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73953788 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72969354 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69642846 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69262662 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.66940481 |
| 33 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.66759362 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62983964 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50732277 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46960207 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45982904 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45626931 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.42226331 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41271152 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.40611274 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39849590 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.33777249 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31775390 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30050949 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27365544 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24675435 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21004792 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14940141 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13016458 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12922309 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.12697772 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12310798 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12270278 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08652344 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08095428 |
| 57 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03280719 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03148026 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01815801 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97194312 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95334400 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94690046 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94360348 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93191322 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91282269 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91138640 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.89810685 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89557588 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.86829786 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82439551 |
| 71 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.81095216 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76697473 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.76062127 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.75750144 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75297404 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74953043 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.73827295 |
| 78 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73631904 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.72075518 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67363918 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66125785 |
| 82 | Pathways in cancer_Homo sapiens_hsa05200 | 0.65401582 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64465889 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64274316 |
| 85 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58571319 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58076271 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56067119 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53623744 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.53043327 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51881643 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51794002 |
| 92 | Melanoma_Homo sapiens_hsa05218 | 0.50567499 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48851301 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48724352 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48523369 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47854725 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.47056460 |
| 98 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.46810983 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46530405 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45902981 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45336141 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44764380 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41508392 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.39407465 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38745650 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37159936 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36212445 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34594323 |
| 109 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32791504 |
| 110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.32349471 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32091193 |
| 112 | Axon guidance_Homo sapiens_hsa04360 | 0.31983461 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31893803 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31457956 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29848663 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28884428 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27041397 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.25533359 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23012743 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.22645263 |
| 121 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22252635 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21290271 |
| 123 | Base excision repair_Homo sapiens_hsa03410 | 0.21072845 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20293000 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19988337 |
| 126 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.18907751 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18049726 |
| 128 | Other glycan degradation_Homo sapiens_hsa00511 | 0.15127501 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.13803895 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.13663107 |
| 131 | Pertussis_Homo sapiens_hsa05133 | 0.12720840 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.09942678 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.08350717 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.08259397 |
| 135 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.07040944 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.04981287 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04872727 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.03683040 |
| 139 | Focal adhesion_Homo sapiens_hsa04510 | 0.03671974 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.00692313 |
| 141 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.00584566 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0175688 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0172092 |
| 144 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0162508 |
| 145 | Antigen processing and presentation_Homo sapiens_hsa04612 | -0.0119737 |
| 146 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0078611 |
| 147 | Rap1 signaling pathway_Homo sapiens_hsa04015 | -0.0057665 |
| 148 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0053237 |
| 149 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0028493 |

